A prospective study evaluated the clinical and economic impact of transitioning anticancer therapy delivery to community-based care for patients with metastatic breast cancer.

Patients receiving acalabrutinib or zanubrutinib required fewer laboratory and hematology/oncology visits than those treated with ibrutinib.

PDAC cases exhibited steeper declines than controls in subcutaneous fat index and visceral fat index in the 36 months before diagnosis.

Researchers explored oncology nurses' perspectives on administering home-based parenteral antineoplastic therapy, focused on implementation barriers and facilitators.

Researchers assessed the impact of pretreatment counseling on patient-reported outcomes in patients with hepatocellular carcinoma on immunotherapy.

Researchers evaluated cases of immune checkpoint inhibitor-induced autoimmune hemolytic anemia to better understand its clinical characteristics, timing, and treatment management.

Investigators evaluated a blood-based, machine learning-enhanced multigene transcript assay for its ability to detect disease ...

Researchers evaluated the effect of selective estrogen receptor modulators on lipid metabolism and fatty liver disease risk in women with breast cancer.

HealthDay News — Low-risk prostate cancer (PC) has become less common at diagnosis since 2010, and low-risk patients are increasingly avoiding treatment, according to a study published online Oct. 26 ...

Adding intismeran to pembrolizumab linked to reduced risk for recurrence, death for surgically resected melanoma.

Investigators assessed the relationship between distinct symptom clusters and quality of life in patients who underwent thyroid cancer surgery.

Researchers evaluated the impact of CHIP and pre-treatment neutropenia on outcomes in patients receiving CAR T-cell therapy.